earnings
IN
NASDAQ · INDP
Indaptus Therapeutics, Inc.
Healthcare · Biotechnology
$3.64
Up+$0.50 (+15.92%)
Updated Sep 16, 2026, 12:06 PM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.47M
- P/E ratio
- -0.09
- Dividend yield
- 0.00%
- 52-week range
- $0.92 – $8.57
- Volume
- 1.96M
- Avg. volume
- 521.72K
Price performance
INDP price history
1M range · 20 trading sessions · Daily adjusted prices
INDP closed at $3.64 after 20 trading sessions, up 288.85% for the selected period.
- Last close
- $3.64
- Period change
- +288.85%
- Period low
- $0.94
- Period high
- $3.64
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $3.40 | $3.6947 | $3.05 | $3.64 | 1.96M |
| Sep 14, 2026 | $2.80 | $3.18 | $2.69 | $3.14 | 1.39M |
| Sep 11, 2026 | $2.70 | $2.94 | $2.46 | $2.77 | 1.8M |
| Sep 10, 2026 | $2.00 | $2.63 | $1.97 | $2.56 | 3.18M |
| Sep 9, 2026 | $1.92 | $2.39 | $1.89 | $2.08 | 5.68M |
| Sep 8, 2026 | $1.285 | $1.94 | $1.27 | $1.85 | 8.46M |
| Sep 4, 2026 | $1.20 | $1.235 | $1.17 | $1.22 | 133.11K |
| Sep 3, 2026 | $1.16 | $1.19 | $1.14 | $1.16 | 249.92K |
| Sep 2, 2026 | $1.17 | $1.20 | $1.1312 | $1.17 | 331.83K |
| Sep 1, 2026 | $1.10 | $1.162 | $1.10 | $1.13 | 75.3K |
| Aug 31, 2026 | $1.14 | $1.17 | $1.09 | $1.145 | 140.26K |
| Aug 28, 2026 | $1.16 | $1.1845 | $1.10 | $1.14 | 104.08K |
| Aug 27, 2026 | $1.13 | $1.24 | $1.09 | $1.16 | 404.59K |
| Aug 26, 2026 | $1.09 | $1.16 | $1.06 | $1.14 | 206.02K |
| Aug 25, 2026 | $1.15 | $1.18 | $1.09 | $1.095 | 497.16K |
| Aug 24, 2026 | $1.24 | $1.29 | $1.13 | $1.16 | 293.73K |
| Aug 21, 2026 | $1.39 | $1.58 | $1.18 | $1.29 | 1.14M |
| Aug 20, 2026 | $0.9419 | $1.42 | $0.94 | $1.38 | 11.75M |
| Aug 19, 2026 | $0.9361 | $1.11 | $0.925 | $0.94 | 813.18K |
| Aug 18, 2026 | $1.00 | $1.02 | $0.92 | $0.9361 | 341.45K |
Latest INDP news
The latest Smart Investors Daily articles mentioning INDP.
Stock researchMarket Activity · Short Interest
Loading stock research…